To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
Trial · NCT01496313
Adverse event totals18
The totals the trial posted for each group.
1 to 18 of 18
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Randomized Period: Vandetanib 150 mg | 1 | 40 |
| Total, all-cause mortality | Randomized Period: Vandetanib 300 mg | 6 | 41 |
| Total, all-cause mortality | Open-label Period: Vandetanib 100 mg | 0 | 5 |
| Total, all-cause mortality | Open-label Period: Vandetanib 150 mg | 0 | 9 |
| Total, all-cause mortality | Open-label Period: Vandetanib 200 mg | 1 | 8 |
| Total, all-cause mortality | Open-label Period: Vandetanib 300 mg | 10 | 39 |
| Total, other adverse events | Randomized Period: Vandetanib 150 mg | 38 | 40 |
| Total, other adverse events | Randomized Period: Vandetanib 300 mg | 40 | 41 |
| Total, other adverse events | Open-label Period: Vandetanib 100 mg | 5 | 5 |
| Total, other adverse events | Open-label Period: Vandetanib 150 mg | 7 | 9 |
| Total, other adverse events | Open-label Period: Vandetanib 200 mg | 7 | 8 |
| Total, other adverse events | Open-label Period: Vandetanib 300 mg | 31 | 39 |
| Total, serious adverse events | Randomized Period: Vandetanib 150 mg | 9 | 40 |
| Total, serious adverse events | Randomized Period: Vandetanib 300 mg | 9 | 41 |
| Total, serious adverse events | Open-label Period: Vandetanib 100 mg | 0 | 5 |
| Total, serious adverse events | Open-label Period: Vandetanib 150 mg | 4 | 9 |
| Total, serious adverse events | Open-label Period: Vandetanib 200 mg | 2 | 8 |
| Total, serious adverse events | Open-label Period: Vandetanib 300 mg | 11 | 39 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01496313/event-totals